Drugs like Ozempic, Wegovy and Mounjaro are changing the game for weight loss. GLP-1 medications were originally intended to ...
The governor also said she would work with other states to leverage their combined purchasing power to reduce the cost of the ...
The podcast features Numerator Chief Economist Leo Feler, who talks about the potential impact of GLP-1 drugs like Ozempic ...
Korea Joongang Daily on MSN14h
Hanmi seeks to gain on Wegovy with its own weight-loss drugHanmi Pharmaceutical Senior Vice President Choi In-young, head of the R&D center, speaks to Korean media outlets at a press conference held in San Francisco, California, on Jan. 15. [LEE JAE-LIM] SAN ...
When it comes to weight loss drugs, Ozempic has become a phenomenon. With nearly $14 billion in sales in 2023, it shows no ...
The weight-loss succession race is heating up. Here's how biopharma execs talked up those efforts at JPM this week.
Investor's Business Daily on MSN21h
After Eli Lilly's 7% Slump On Its Guidance Cut, What's Left To Like? A Lot, Says One Analyst.There's still a lot to like about Eli Lilly stock, an analyst said Wednesday after the weight-loss drugs kingpin cut its sales view.
Guy's is one of the first hospitals in the country to roll out weight-loss jabs. But whilst millions across the ...
Eli Lilly trims Q4 guidance but maintains optimism with promising drugs like Zepbound for sleep apnea and global launches ...
Wegovy (semaglutide ... Professor of Endocrinology at Ulster University. Only making the drug available through weight-loss programmes is another barrier to access, as there are not enough ...
US government settle patent case over HIV prevention drugs January 15, 2025 Healthcare & Pharmaceuticalscategory US bans use of Red No.3 dye in food, drugs over potential cancer links January 15 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback